Primary |
Anaesthesia Procedure |
13.0% |
Nerve Block |
13.0% |
Anaesthesia |
11.6% |
Analgesic Therapy |
11.6% |
Local Anaesthesia |
11.6% |
Depression |
4.3% |
Induction Of Anaesthesia |
4.3% |
Product Used For Unknown Indication |
4.3% |
Sedation |
4.3% |
Cataract Operation |
2.9% |
Convulsion |
2.9% |
General Anaesthesia |
2.9% |
Hypertension |
2.9% |
Anaesthetic Premedication |
1.4% |
Bursitis |
1.4% |
Dental Operation |
1.4% |
Diabetes Mellitus |
1.4% |
Epidural Anaesthesia |
1.4% |
Hip Fracture |
1.4% |
Maintenance Of Anaesthesia |
1.4% |
|
Oxygen Saturation Decreased |
11.1% |
Retinal Artery Occlusion |
11.1% |
Diplopia |
7.4% |
Generalised Erythema |
7.4% |
Ventricular Fibrillation |
7.4% |
Anaphylactic Reaction |
3.7% |
Cardiac Arrest |
3.7% |
Cardiomyopathy Neonatal |
3.7% |
Drug Effect Decreased |
3.7% |
Dysphagia |
3.7% |
Dyspnoea |
3.7% |
Guillain-barre Syndrome |
3.7% |
Heart Rate Increased |
3.7% |
Hypotension |
3.7% |
Labelled Drug-food Interaction Medication Error |
3.7% |
Laryngeal Oedema |
3.7% |
Localised Oedema |
3.7% |
Muscle Twitching |
3.7% |
Myocardial Ischaemia |
3.7% |
Nervous System Disorder |
3.7% |
|
Secondary |
Maintenance Of Anaesthesia |
14.1% |
Nerve Block |
10.7% |
Anaesthesia |
9.0% |
Analgesic Therapy |
7.3% |
Product Used For Unknown Indication |
6.8% |
Musculoskeletal Pain |
6.2% |
Anaesthesia Procedure |
4.5% |
Drug Use For Unknown Indication |
4.5% |
Premedication |
4.5% |
Induction Of Anaesthesia |
4.0% |
Local Anaesthesia |
4.0% |
Pain |
4.0% |
General Anaesthesia |
3.4% |
Hypertension |
3.4% |
Surgery |
3.4% |
Arthralgia |
2.3% |
Epidural Anaesthesia |
2.3% |
Eye Irrigation |
2.3% |
Dental Care |
1.7% |
Depression |
1.7% |
|
Hypotension |
17.6% |
Grand Mal Convulsion |
8.8% |
Bile Duct Cancer |
5.9% |
Erythema |
5.9% |
Generalised Erythema |
5.9% |
Hyperthermia Malignant |
5.9% |
No Adverse Event |
5.9% |
Paraesthesia Oral |
5.9% |
Thirst |
5.9% |
Agitation |
2.9% |
Angle Closure Glaucoma |
2.9% |
Anterior Spinal Artery Syndrome |
2.9% |
Arthritis Bacterial |
2.9% |
Corneal Opacity |
2.9% |
Drug Eruption |
2.9% |
Holmes-adie Pupil |
2.9% |
Hypertension |
2.9% |
Laryngeal Oedema |
2.9% |
Lung Neoplasm Malignant |
2.9% |
Musculoskeletal Pain |
2.9% |
|
Concomitant |
Pain |
11.5% |
Anaesthesia |
9.0% |
Ill-defined Disorder |
8.7% |
Drug Use For Unknown Indication |
7.6% |
Fibromyalgia |
6.9% |
General Anaesthesia |
6.6% |
Induction Of Anaesthesia |
6.3% |
Product Used For Unknown Indication |
4.9% |
Breast Cancer |
4.5% |
Prophylaxis |
4.5% |
Anaesthetic Premedication |
3.8% |
Granulocytopenia |
3.5% |
Local Anaesthesia |
3.5% |
Maintenance Of Anaesthesia |
3.5% |
Dyspepsia |
3.1% |
Ovarian Operation |
2.8% |
Postoperative Analgesia |
2.8% |
Neuropathy Peripheral |
2.4% |
Blood Pressure Increased |
2.1% |
Surgery |
2.1% |
|
Weight Decreased |
13.3% |
Peripheral Nerve Injury |
8.9% |
Urine Output Decreased |
8.9% |
Delirium |
6.7% |
Weight Increased |
6.7% |
Drug Intolerance |
4.4% |
Dysarthria |
4.4% |
Haemorrhoids |
4.4% |
Hypotension |
4.4% |
Pruritus Generalised |
4.4% |
Renal Impairment |
4.4% |
Respiratory Arrest |
4.4% |
Respiratory Depression |
4.4% |
Spinal Cord Infarction |
4.4% |
Visual Acuity Reduced |
4.4% |
Agranulocytosis |
2.2% |
Angioedema |
2.2% |
Arteriosclerosis |
2.2% |
Atrioventricular Block Second Degree |
2.2% |
Bronchospasm |
2.2% |
|
Interacting |
|
|